The head of National Committee on Vaccination Activities against COVID-19 (CNCAV), Valeriu Gheorghita, said that next week the city of Bucharest will “most likely” pass a 70% vaccination coverage rate with at least one dose.
“If we look at the vaccination coverage rate in Bucharest and at the level of each county, Bucharest is currently at about 65% vaccination coverage rate in the eligible population over 12 years. It is very likely that next week Bucharest will be the first to pass the 70% vaccination coverage rate with at least one dose. We have three other counties that have a vaccination coverage rate of over 50%, namely: Cluj, with 57%, Constanta – 54%, and Sibiu – 51%. We have 19 counties that have a vaccination rate between 40 and 50%, 17 counties between 30 and 40% and we have two more counties that have a vaccination rate between 27 and 29%,” Valeriu Gheorghita told a Tuesday’s press conference at Victoria Palace.
He mentioned that, from the beginning of the vaccination campaign, from December 27, 2020, and until November 15, in Romania 7.48 million people were vaccinated with at least one dose and 6.89 million people with full scheme.
The head of CNCAV specified that, at European level, the vaccination rate is about 61% with at least one dose and about 57-58% with a complete scheme.
Logistical preparations for vaccination of children aged between 5 and 11 years to be ready by the end of this month
Valeriu Gheorghita also estimates that the logistical preparations regarding the vaccination against COVID-19 of children aged between 5 and 11 years will be ready by the end of this month.
“We said last week that the authorization from the European Medicines Agency is expected in mid-December, but the latest calendar is ahead of schedule and we expect to have this authorization earlier, in the second half of November, maybe the end of November (…) we will probably have the opinion of the European Medicines Agency on November 25, while in the case of the vaccine from the company Moderna, which also submitted the documentation for evaluation with the European Medicines Agency, the authorization is expected to be granted in mid-December,” Gheorghita told press conference on Tuesday.
He recalled that vaccination campaigns for this age group are already underway in the United States and Israel.
At the same time, children up to the age of 11 will also be able to get the vaccine in centres where there is a vaccine from BioNTech Pfizer for the vaccination of children over 12 years.